Takeda is buying Adderall maker Shire for $64 billion in pharma’s biggest deal of the year

“Takeda has reached a preliminary agreement to buy Adderall drugmaker Shire for $64 billion in the largest pharma deal of the year” writes Lydia Ramsey for businessinsider.com. US drugmaker AbbVie nearly acquired the company in 2014, but the deal collapsed due to changes in US tax law.The deal strengthens the Japanese drugmakers’ footprint in the US, where Shire has a large presence, and also expands its position in rare diseases like hemophilia.